Similar content being viewed by others
This article is cited by
-
Investigating genetic variants for treatment response to selective serotonin reuptake inhibitors in syndromal factors and side effects among patients with depression in Taiwanese Han population
The Pharmacogenomics Journal (2023)
-
Prenatal risk factors and neonatal DNA methylation in very preterm infants
Clinical Epigenetics (2021)
-
Targeted exome sequencing identifies five novel loci at genome-wide significance for modulating antidepressant response in patients with major depressive disorder
Translational Psychiatry (2020)
-
Genome-wide association study of antidepressant response: involvement of the inorganic cation transmembrane transporter activity pathway
BMC Psychiatry (2016)
-
TSPAN5, ERICH3 and selective serotonin reuptake inhibitors in major depressive disorder: pharmacometabolomics-informed pharmacogenomics
Molecular Psychiatry (2016)